These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 12535403)

  • 1. Mycobacterium vaccae immunotherapy for treating tuberculosis.
    de Bruyn G; Garner P
    Cochrane Database Syst Rev; 2003; (1):CD001166. PubMed ID: 12535403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycobacterium vaccae immunotherapy for treating tuberculosis.
    de B; Garner P
    Cochrane Database Syst Rev; 2001; (1):CD001166. PubMed ID: 11279709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycobacterium vaccae immunotherapy for treating tuberculosis.
    de Bruyn G; Garner P
    Cochrane Database Syst Rev; 2000; 2003(2):CD001166. PubMed ID: 10796609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Mycobacterium vaccae immunotherapy for patients with tuberculosis: A systematic review and meta-analysis.
    Huang CY; Hsieh WY
    Hum Vaccin Immunother; 2017 Sep; 13(9):1960-1971. PubMed ID: 28604170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy with Mycobacterium vaccae as an addition to chemotherapy for the treatment of pulmonary tuberculosis under difficult conditions in Africa.
    Onyebujoh PC; Abdulmumini T; Robinson S; Rook GA; Stanford JL
    Respir Med; 1995 Mar; 89(3):199-207. PubMed ID: 7746913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy with Mycobacterium vaccae in the treatment of tuberculosis.
    Stanford J; Stanford C; Grange J
    Front Biosci; 2004 May; 9():1701-19. PubMed ID: 14977580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy with Mycobacterium vaccae in patients with newly diagnosed pulmonary tuberculosis: a randomised controlled trial. Durban Immunotherapy Trial Group.
    Lancet; 1999 Jul; 354(9173):116-9. PubMed ID: 10408487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycobacterium w Immunotherapy for Treating Pulmonary Tuberculosis - a Systematic Review.
    Pandie S; Engel ME; Kerbelker ZS; Mayosi BM
    Curr Pharm Des; 2014; 20(39):6207-14. PubMed ID: 25190062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized controlled trial of Mycobacterium vaccae immunotherapy in non-human immunodeficiency virus-infected ugandan adults with newly diagnosed pulmonary tuberculosis. The Uganda-Case Western Reserve University Research Collaboration.
    Johnson JL; Kamya RM; Okwera A; Loughlin AM; Nyole S; Hom DL; Wallis RS; Hirsch CS; Wolski K; Foulds J; Mugerwa RD; Ellner JJ
    J Infect Dis; 2000 Apr; 181(4):1304-12. PubMed ID: 10753731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind placebo-controlled trial of Mycobacterium vaccae immunotherapy for tuberculosis in KwaZulu, South Africa, 1991-97.
    Mayo RE; Stanford JL
    Trans R Soc Trop Med Hyg; 2000; 94(5):563-8. PubMed ID: 11132390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological consequences of three doses of heat-killed Mycobacterium vaccae in the immunotherapy of tuberculosis.
    Dlugovitzky D; Fiorenza G; Farroni M; Bogue C; Stanford C; Stanford J
    Respir Med; 2006 Jun; 100(6):1079-87. PubMed ID: 16278080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The immunotherapeutic effect of Mycobacterium vaccae vaccine on initially treated pulmonary tuberculosis].
    Luo Y;
    Zhonghua Jie He He Hu Xi Za Zhi; 2001 Jan; 24(1):43-7. PubMed ID: 11802939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A clinical study on vaccine of Mycobacterium vaccae in treating pulmonary tuberculosis].
    Wang W; Jin G; Ye Y; Xia X; Wang A; Zhuang Y; Li G; Sun H; Wang Z; Lin M; Chen H; Li J; Dan Z; Zhang X
    Zhonghua Jie He He Hu Xi Za Zhi; 1999 Feb; 22(2):108-10. PubMed ID: 11820954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low level laser therapy for treating tuberculosis.
    Vlassov VV; Pechatnikov LM; MacLehose HG
    Cochrane Database Syst Rev; 2002; (3):CD003490. PubMed ID: 12137698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orally administered Mycobacterium vaccae modulates expression of immunoregulatory molecules in BALB/c mice with pulmonary tuberculosis.
    Hernández-Pando R; Aguilar D; Orozco H; Cortez Y; Brunet LR; Rook GA
    Clin Vaccine Immunol; 2008 Nov; 15(11):1730-6. PubMed ID: 18827195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy with Mycobacterium vaccae and the treatment of tuberculosis.
    Stanford JL; Stanford CA
    Soc Appl Bacteriol Symp Ser; 1996; 25():81S-86S. PubMed ID: 8972123
    [No Abstract]   [Full Text] [Related]  

  • 17. Mycobacterium vaccae as adjuvant therapy to anti-tuberculosis chemotherapy in never-treated tuberculosis patients: a meta-analysis.
    Yang XY; Chen QF; Li YP; Wu SM
    PLoS One; 2011; 6(9):e23826. PubMed ID: 21909406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential for immunotherapy with heat-killed Mycobacterium vaccae in respiratory medicine.
    Stanford J; Stanford C; Dlugovitzky D; Fiorenza G; Martinel-Lamas D; Selenscig D; Bogue C
    Immunotherapy; 2009 Nov; 1(6):933-47. PubMed ID: 20635912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whither Mycobacterium vaccae?
    Reichman LB
    Lancet; 1999 Jul; 354(9173):90. PubMed ID: 10408480
    [No Abstract]   [Full Text] [Related]  

  • 20. Interventions for treating tuberculous pericarditis.
    Wiysonge CS; Ntsekhe M; Thabane L; Volmink J; Majombozi D; Gumedze F; Pandie S; Mayosi BM
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD000526. PubMed ID: 28902412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.